Early-Stage Non-Small Cell Lung Cancer

Early-stage NSCLC can be managed curatively with either surgery or radiotherapy. Here, we discuss evidence for managing early-stage disease with surgery and considerations for adjuvant or neoadjuvant systemic therapy. Then, we discuss the evidence-base for SBRT for early-stage NSCLC and factors to consider when determining appropriate dose-fractionation. This presentation is created purely for educational purposes and does NOT constitute medical advice. If there are any errors or questions/concerns, we welcome comments and discussion!